Drug General Information
Drug ID
D01UDV
Former ID
DNC000813
Drug Name
ISIS 5132
Drug Type
Small molecular drug
Indication Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] Phase 2 [525152]
Formula
C193H247N68O102P19S19
Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(<br />O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S<br />)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(<br />=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=O)(OC1CC(OC1COP(<br />=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO<br />P(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1<br />COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(O<br />C1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N<br />)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)<br />N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)<br />N)N1C=C(C(=O)NC1=O)C)S)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1<br />N=CN=C2N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=CN=C2N)N1C=C(C(=O)<br />NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C<br />1N=CN=C2N)N1C=C(C(=O)NC1=O)C)O
InChI
1S/C193H247N68O102P19S19/c1-77-41-249(188(281)236-167(77)264)130-21-83(263)104(326-130)48-306-364(287,383)353-92-30-139(251-43-79(3)169(266)238-190(251)283)334-112(92)56-315-379(302,398)358-97-35-144(256-71-215-151-158(202)209-68-212-161(151)256)338-116(97)60-319-371(294,390)351-91-29-137(248-20-13-129(200)227-187(248)280)333-111(91)55-313-378(301,397)361-100-38-147(259-74-218-154-164(259)229-178(205)233-174(154)271)342-120(100)64-322-374(297,393)355-94-32-141(253-45-81(5)171(268)240-192(253)285)336-114(94)58-316-380(303,399)359-98-36-145(257-72-216-152-159(203)210-69-213-162(152)257)339-117(98)61-318-370(293,389)350-90-28-136(247-19-12-128(199)226-186(247)279)331-109(90)53-311-376(299,395)357-96-34-143(255-70-214-150-157(201)208-67-211-160(150)255)340-118(96)62-320-382(305,401)363-102-40-149(261-76-220-156-166(261)231-180(207)235-176(156)273)344-122(102)66-324-375(298,394)356-95-33-142(254-46-82(6)172(269)241-193(254)286)337-115(95)59-317-381(304,400)362-101-39-148(260-75-219-155-165(260)230-179(206)234-175(155)272)343-121(101)65-323-373(296,392)354-93-31-140(252-44-80(4)170(267)239-191(252)284)335-113(93)57-314-369(292,388)349-88-26-134(245-17-10-126(197)224-184(245)277)329-107(88)51-309-368(291,387)348-87-25-133(244-16-9-125(196)223-183(244)276)332-110(87)54-312-377(300,396)360-99-37-146(258-73-217-153-163(258)228-177(204)232-173(153)270)341-119(99)63-321-372(295,391)352-89-27-135(246-18-11-127(198)225-185(246)278)330-108(89)52-310-367(290,386)347-86-24-132(243-15-8-124(195)222-182(243)275)328-106(86)50-308-366(289,385)346-85-23-131(242-14-7-123(194)221-181(242)274)327-105(85)49-307-365(288,384)345-84-22-138(325-103(84)47-262)250-42-78(2)168(265)237-189(250)282/h7-20,41-46,67-76,83-122,130-149,262-263H,21-40,47-66H2,1-6H3,(H,287,383)(H,288,384)(H,289,385)(H,290,386)(H,291,387)(H,292,388)(H,293,389)(H,294,390)(H,295,391)(H,296,392)(H,297,393)(H,298,394)(H,299,395)(H,300,396)(H,301,397)(H,302,398)(H,303,399)(H,304,400)(H,305,401)(H2,194,221,274)(H2,195,222,275)(H2,196,223,276)(H2,197,224,277)(H2,198,225,278)(H2,199,226,279)(H2,200,227,280)(H2,201,208,211)(H2,202,209,212)(H2,203,210,213)(H,236,264,281)(H,237,265,282)(H,238,266,283)(H,239,267,284)(H,240,268,285)(H,241,269,286)(H3,204,228,232,270)(H3,205,229,233,271)(H3,206,230,234,272)(H3,207,231,235,273)
InChIKey
OMEUGRCNAZNQLN-UHFFFAOYSA-N
CAS Number
CAS 177075-18-2
PubChem Compound ID
Target and Pathway
Target(s) Proto-oncogene c-RAF Target Info Modulator
References
Ref 525152ClinicalTrials.gov (NCT02417753) AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.